Ticker | Company | Zen Score | Valuation Score | Financials Score | Forecast Score | Performance Score | Dividends Score |
---|---|---|---|---|---|---|---|
CCRN | CROSS COUNTRY HEALTHCARE INC | 70 | 100 | 86 | 44 | 50 | – |
CORT | CORCEPT THERAPEUTICS INC | 67 | 71 | 71 | 56 | 70 | – |
KMDA | KAMADA LTD | 65 | 86 | 86 | 67 | 20 | – |
INCY | INCYTE CORP | 64 | 86 | 86 | 56 | 30 | – |
NBIX | NEUROCRINE BIOSCIENCES INC | 64 | 43 | 86 | 67 | 60 | – |
Upgrade to Premium to View MoreUse Zen Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail. Already have a premium account? Sign In |
Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
679 | -0.04% | +0.91% | +3.56% | -18.59% | 8.43x | 6.06x | +18.39% | +3.73% | -27.83% | +76.96% | Strong Buy | ||
64 | -0.44% | +7.25% | +11.82% | +11.92% | 38.80x | 4.48x | -13.29% | +6.45% | +11.46% | +4.67% | Buy | ||
18 | -1.13% | +1.15% | +7.58% | +17.63% | 31.18x | 6.42x | +33.58% | +8.09% | +14.21% | +10.87% | Buy | ||
88 | +0.20% | +1.16% | +5.36% | -1.14% | -1.18x | 2.20x | +12.32% | +3.31% | +5.98% | +31.51% | Strong Buy | ||
12 | +0.46% | +1.09% | +5.04% | +5.89% | 25.41x | 3.05x | +15.18% | +4.74% | +11.78% | +12.50% | Buy | ||
61 | +0.42% | +0.73% | -1.16% | -19.05% | 5.93x | 3.31x | +6.57% | +2.11% | +5.22% | +27.52% | Buy | ||
51 | -1.02% | +0.20% | +4.10% | +11.73% | 40.97x | 4.60x | -92.21% | +6.56% | +13.62% | +14.66% | Buy | ||
150 | -0.36% | +1.22% | +1.80% | -12.40% | 30.63x | 4.00x | +7.26% | +5.26% | +8.15% | +19.56% | Buy | ||
10 | +0.42% | +0.06% | -0.15% | +26.26% | 26.60x | 106.30x | -10.85% | +3.43% | +19.53% | +10.05% | Buy | ||
56 | -1.50% | +2.24% | +5.10% | -6.26% | 59.50x | 3.63x | +11.22% | +7.71% | +10.03% | +17.89% | Buy |